Cheyne Capital Management (UK)’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-41,320
| Closed | -$709K | – | 37 |
|
|
2015
Q4 | $709K | Sell |
41,320
-80,219
| -66% | -$1.38M | 0.38% | 24 |
|
|
2015
Q3 | $2.56M | Sell |
121,539
-26,866
| -18% | -$565K | 1.2% | 11 |
|
|
2015
Q2 | $7.34M | Sell |
148,405
-36
| -0% | -$1.78K | 2.37% | 6 |
|
|
2015
Q1 | $11.6M | Buy |
148,441
+42,575
| +40% | +$3.33M | 2.8% | 11 |
|
|
2014
Q4 | $6.42M | Buy |
105,866
+36,502
| +53% | +$2.21M | 1.69% | 11 |
|
|
2014
Q3 | $2.96M | Buy |
+69,364
| New | +$2.96M | 1.05% | 15 |
|